课题基金 / 基金详情

Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures

Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
批准号:
9272954
负责人:
RAYMOND J DINGLEDINE
金额:
$42.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-15 至 2021-04-30
关键词:
AblationAcuteAddressAlbuminsAlzheimer&aposs DiseaseAmygdaloid structureAmyotrophic Lateral SclerosisAnimal ModelAnxietyAppearanceAstrocytesBehavioral AssayBloodBlood - brain barrier anatomyBlood VesselsBrainBrain InjuriesCapillary Endothelial CellCellsChronicCognitive deficitsComorbidityConditioned Culture MediaCortical DysplasiaCyclic AMP-Dependent Protein KinasesDevelopmentDinoprostoneDiseaseDown-RegulationElectroencephalographyElementsEncephalitisEpilepsyEpileptogenesisEventFlow CytometryFluorescein-5-isothiocyanateGenesGeneticGliosisImmuneIn VitroInfectionInfiltrationInflammationInflammation MediatorsInflammatoryInterleukin-1Interleukin-6Knock-outKnockout MiceLifeMaintenanceMeasuresMediatingMediator of activation proteinMessenger RNAMicrogliaModelingModificationMolecularMolecular TargetMorbidity - disease rateMultiple SclerosisMusNeurodegenerative DisordersNeurological emergenciesNeuronsPTGS2 genePathway interactionsPharmacologyPilocarpinePlayPopulationPrincipal InvestigatorProductionProsencephalonProstaglandin ReceptorProteinsQuantitative Reverse Transcriptase PCRReactionRecruitment ActivityRefractoryRodentRoleSeizuresSeriesSerum AlbuminSignal PathwayStatus EpilepticusStrokeTNF geneTestingVascular Endothelial CellWestern BlottingWorkaging brainarrestin 1arrestin 2cell typechemokinecyclooxygenase 2cytokinedesignin vitro Modelin vivointerestkainatemalformationmanmonocytemouse modelneuroinflammationneutralizing antibodyneutrophilnovelobject recognitionpreventprogramsreceptorsmall moleculetool

项目摘要

项目成果

RAYMOND J DINGLEDINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Accumulating evidence in animal models highlights that inflammation ensuing in the brain during status epilepticus (SE) may play a determinant role in ongoing seizures and their long-term detrimental consequences, independent of an infection or auto-immune cause. Studies in a multitude of animal models demonstrate that SE causes a rapid and intense inflammatory cascade in the forebrain involving interactions among neurons, reactive astrocytes, activated microglia, vascular endothelial cells and, eventually, infiltrating neutrophils and monocytes from the blood. The pathophysiological interactions among the various inflammatory molecules, and the sequence of events leading to their induction, have not yet been dissected. The broad cytokine burst and gliosis following SE is blunted in mice that have genetic ablations of COX-2 restricted to those principal forebrain neurons in which COX-2 is normally induced by SE, pointing to a role for COX-2 pathways in SE-induced inflammation including breakdown of the blood-brain barrier (BBB), which is sufficient to produce epilepsy. Previous work showed that the EP2 receptor mediates much of the COX-2 effect. We hypothesize that SE-related morbidity is largely due to activation of microglial EP2 receptors, which modulates production of cytokines that degrade the BBB. Our specific aims are: 1. To test the hypothesis that activated microglia rather than inflammatory monocytes are responsible for EP2- regulated BBB breakdown after seizures; 2. To test the hypothesis that IL- -secreted mediator and Epac the major EP2 signaling pathway that degrades the integrity of the blood-brain barrier after SE; 3. To determine whether EP2 activation plays a dominant role in the development of epilepsy or its comorbidities after SE. To address these aims we employ in vitro culture models of the BBB and in vivo SE models with cell- specific conditional knockouts of EP2. Immunohistochemical, western blot, FACS, qRT-PCR, EEG and behavioral assays are performed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10467539
  • 项目类别:
  • 资助金额:
    $67.75万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
  • 批准号:
    10732636
  • 项目类别:
  • 资助金额:
    $67.95万
  • 财政年份:
    2022
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10356163
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
  • 批准号:
    10171930
  • 项目类别:
  • 资助金额:
    $52.02万
  • 财政年份:
    2020
  • 负责人:
    RAYMOND J DINGLEDINE
  • 依托单位:
海外基金